Pioneering diagnostics

Timeline

  • 1963

    Establishment of BD Mérieux

    close
    1963
    photo-1963

    1963

    Establishment of BD Mérieux

  • 1967

    Launch by BD Mérieux of a fibrometer

    close
    1967
    photo-1967

    1967

    Launch by BD Mérieux of a fibrometer

    The fibrometer is added to the BD Mérieux catalog to test blood coagulation and is quickly adopted by a quarter (approx. 1,000) of France’s laboratories.

  • 1969

    The first toxoplasmosis detection kit and launch of miniaturized API® 20E strip

    close
    1969
    photo-1969

    1969

    The first toxoplasmosis detection kit and launch of miniaturized API® 20E strip

    • The first toxoplasmosis detection kit: diagnosis of toxoplasmosis by immunofluorescence.
    • Launch of miniaturized API® 20E strip by Api System*

    *Api System was acquired by bioMérieux in 1987.

  • 1972

    Production and sale of the first ready-to-use culture media in Petri plates.

    close
    1972
    photo-1972

    1972

    Production and sale of the first ready-to-use culture media in Petri plates.

  • 1974

    Alain Mérieux takes control of BD Mérieux, which becomes bioMérieux.

    close
    1974
    photo-1974

    1974

    Alain Mérieux takes control of BD Mérieux, which becomes bioMérieux.

  • 1974

    Launch of the Slidex® Meningitis kit.

    close
    1974
    photo-1974

    1974

    Launch of the Slidex® Meningitis kit.

    First test enabling the diagnosis of an infectious disease without prior culture, with results in 5 minutes compared to several days previously.

  • 1979

    ATB™ strip

    close
    1979
    photo-1979

    1979

    ATB™ strip

    First ATB™ Antibiotic Susceptibility test strip by Api System*

    *Api System was acquired by bioMérieux in 1987

  • 1985

    First HIV screening test: VIRONOSTIKA® HIV anti-HTLV-III by Organon Teknika*

    close
    1985
    photo-1985

    1985

    First HIV screening test: VIRONOSTIKA® HIV anti-HTLV-III by Organon Teknika*

    *Organon Teknika was acquired by bioMérieux in 2001

  • 1986

    Acquisition of Api Systems (La Balme, France).

    close
    1986
    photo-1986

    1986

    Acquisition of Api Systems (La Balme, France).

    A specialist in bacterial identification and antibiotic susceptibility testing systems.

    • ATB™ EXPRESSION™ et ATB™ Plus Expert for automated bacterial identification and antibiotic susceptibility testing
  • 1988

    Acquisition of Vitek Systems (United States)

    close
    1988
    photo-1988

    1988

    Acquisition of Vitek Systems (United States)

    A world leader in automated bacterial identification.

  • 1989

    Development of chromogenic media

    close
    1989
    photo-1989

    1989

    Development of chromogenic media

    Culture media that enables identification of microbial colonies by coloring them.

  • 1990

    Acquisition of the BOOM extraction and NASBA amplification technologies for molecular diagnostics.

    close
    1990
    photo-1990

    1990

    Acquisition of the BOOM extraction and NASBA amplification technologies for molecular diagnostics.

  • 1991

    Launch of the VIDAS® with 8 initial kits

    close
    1991
    photo-1991

    1991

    Launch of the VIDAS® with 8 initial kits

    Today VIDAS has 100 parameters.

  • 1992

    VIDAS® automated immunoassay platform adapted for industrial applications.

    close
    1992
    photo-1992

    1992

    VIDAS® automated immunoassay platform adapted for industrial applications.

  • 1995

    VIDAS® D-Dimer Exclusion™

    close
    1995
    photo-1995

    1995

    VIDAS® D-Dimer Exclusion™

    The first test used to rule out the diagnosis of deep vein thrombosis and pulmonary embolism to be certified by the FDA.

  • 1997

    Launches of BacT/ALERT® 3D and VITEK® 2

    close
    1997
    photo-1997

    1997

    Launches of BacT/ALERT® 3D and VITEK® 2

    • BacT/ALERT® 3D an advanced automated system for microbial detection in blood and sterile body fluid samples from Organon Teknika*
    • VITEK® 2 an automated identification and antibiotic susceptibility testing system for bacteria and fungi
    *Organon Teknika was acquired by bioMérieux in 2001.
  • 2001

    Acquisition of OrganonTeknika (Akzo Nobel, Netherlands).

    close
    2001
    photo-2001

    2001

    Acquisition of OrganonTeknika (Akzo Nobel, Netherlands).

    A pioneering company working in HIV screening and viral load measurement.

  • 2002

    NucliSENS EasyQ® and NucliSENS EasyQ® HIV-1

    close
    2002
    photo-2002

    2002

    NucliSENS EasyQ® and NucliSENS EasyQ® HIV-1

    NucliSENS EasyQ®, a molecular diagnostics platform for amplification and real-time detection.

    NucliSENS EasyQ® HIV-1, the first real-time test for measuring HIV-1 viral load.

  • 2004

    bioMérieux is listed on the stock exchange.

    close
    2004
    photo-2004

    2004

    bioMérieux is listed on the stock exchange.

  • 2004

    Launches of TEMPO® and VITEK® 2 Compact

    close
    2004
    photo-2004

    2004

    Launches of TEMPO® and VITEK® 2 Compact

    TEMPO®, for automated enumeration of quality indicators (bacteria, yeast and mold) for the agri-food industry.

    VITEK® 2 Compact, a system for identification and antibiotic susceptibility testing (AST).

  • 2006

    Acquisition of Bacterial Barcodes (USA)

    close
    2006
    photo-2006

    2006

    Acquisition of Bacterial Barcodes (USA)

  • 2007

    Acquisition of Biomedics (Spain) and of BTF (Australia)

    close
    2007
    photo-2007

    2007

    Acquisition of Biomedics (Spain) and of BTF (Australia)

    • Acquisition of Biomedics, manufacturer of culture media.
    • Acquisition of BTF, a specialist in industrial microbiology.
  • 2008

    Joint ventures and Acquisitions

    close
    2008
    photo-2008

    2008

    Joint ventures and Acquisitions

    • Acquisition of AB BIODISK (Sweden), a company internationally recognized for its antimicrobial resistance testing range and particular expertise in susceptibility testing of fastidious and unusual organisms.
    •  Acquisition of AviaraDx (USA), now bioTheranostics, a specialist in the molecular diagnosis of tumorous tissues.
    •  Acquisition of PML Microbiologicals (USA), a company devoted to the development and production of culture media.
    • Joint venture with Sysmex, the Japanese market leader in the field of in vitro diagnostics.
    •  Joint venture with Shanghai Kehua Bio-engineering (China) for the production of microplate immunoassays.

     
     

  • 2009

    Launch of PREVI® Color Gram

    close
    2009
    photo-2009

    2009

    Launch of PREVI® Color Gram

    PREVI® Color Gram for automated Gram staining.

  • 2010

    Acquisition of Meikang Biotech and of Shanghai Zenka Biotechnology.

    close
    2010
    photo-2010

    2010

    Acquisition of Meikang Biotech and of Shanghai Zenka Biotechnology.

    Acquisition of Meikang Biotech (China), a manufacturer of rapid tests.
     
    Acquisition of Shanghai Zenka Biotechnology (China), a specialist in culture media.

  • 2010

    Launch of Myla® middleware

    close
    2010
    photo-2010

    2010

    Launch of Myla® middleware

    • Myla® middleware is a software solution for the optimization of laboratory workflow and clinical information management. It is a complement to FMLA® (Full Microbiology Lab Automation).
    • BacT/ALERT® 3D Dual-T, a microbial detection system used for sterility testing in the biopharmaceutical industry.

     

  • 2011

    Acquisition of AES Laboratoire (France).

    close
    2011
    photo-2011

    2011

    Acquisition of AES Laboratoire (France).

    An industrial microbiology company.

  • 2011

    Acquisition of ARGENE (France)

    close
    2011
    photo-2011

    2011

    Acquisition of ARGENE (France)

    A specialist in molecular biology.

  • 2011

    Launch of VITEK® MS

    close
    2011
    photo-2011

    2011

    Launch of VITEK® MS

    • Launch of VITEK® MS (used in association with the VITEK® 2 system) an automated mass spectrometry microbial identification system for clinical and industrial applications.
    • First bioNexia® rapid tests commercialized by bioMérieux.
    • Inauguration of the laboratory of the future at Marcy l’Étoile, France (over 1,000 visits from biologists and scientists in a year). Development of a similar unit in Saint Louis, Missouri (USA). The laboratories enable discussions to align bioMérieux’s future products and services with customer needs.
  • 2012

    Acquisition of RAS (India) and partnership with Quanterix

    close
    2012
    photo-2012

    2012

    Acquisition of RAS (India) and partnership with Quanterix

    • Acquisition of RAS, a specialist in molecular biology.
    • Partnership with Quanterix for the development of a new generation of ultrasensitive, multiplex immunoassays.
  • 2013

    FDA approval of novel molecular test THxID™-BRAF

    close
    2013
    photo-2013

    2013

    FDA approval of novel molecular test THxID™-BRAF

    A companion test for late stage metastatic melanoma tumor samples.

  • 2013

    VIDAS® 3

    close
    2013
    photo-2013

    2013

    VIDAS® 3

    The new generation of the VIDAS automated immunoassay platform.

  • 2014

    Acquisition of BioFire Diagnostics Inc.

    close
    2014
    photo-2014

    2014

    Acquisition of BioFire Diagnostics Inc.

    Acquisition of BioFire Diagnostics Inc., a privately held US-based company specialized in molecular biology.

  • 2014

    FDA clearance for the FilmArray® Gastrointestinal (GI) Panel

    close
    2014
    photo-2014

    2014

    FDA clearance for the FilmArray® Gastrointestinal (GI) Panel

    The 22-target FilmArray® GI Panel1 allows a syndromic approach2 to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test.

    A test panel is a predetermined group of medical tests used as an aid in the diagnosis and treatment of diseases.

    The syndromic approach is based on analyzing a syndrome (i.e. a set of symptoms) and, with a single reagent, identifying the disease-causing organisms responsible for this syndrome, whether they are viruses, bacteria or parasites.

     

  • 2014

    Launch of CE-marked VIRTUO™

    close
    2014
    photo-2014

    2014

    Launch of CE-marked VIRTUO™

    The new generation of BacT/ALERT®, VIRTUO™ is a uniquely innovative automated blood culture microbial detection system.

  • 2015

    Strategic partnership between bioMérieux and COPAN (Italia)

    close
    2015
    photo-2015

    2015

    Strategic partnership between bioMérieux and COPAN (Italia)

    Strategic partnership in clinical microbiology laboratory automation between bioMérieux and COPAN. Leading manufacturer of innovative pre-analytic solutions, COPAN grants distribution rights for its automated platforms WASP® and WASPLab™.

  • 2015

    Launch of bioMérieux EPISEQ™

    close
    2015
    photo-2015

    2015

    Launch of bioMérieux EPISEQ™

    An innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring of bacterial infections. Result of the collaboration agreement with Illumina, a world leader un genomics.

  • 2015

    Launch of GENE-UP®

    close
    2015
    photo-2015

    2015

    Launch of GENE-UP®

    A new-generation PCR system for customers in the agri-food sector for the detection of microorganisms (bacteria and viruses).

  • 2016

    Acquisition of Applied Maths (Belgium)

    close
    2016
    photo-2016

    2016

    Acquisition of Applied Maths (Belgium)

    bioMérieux enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data.

  • 2016

    FilmArray® Torch is FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked

    close
    2016
    photo-2016

    2016

    FilmArray® Torch is FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked

    The FilmArray® Torch platform is FDA-cleared for use with the Respiratory, Blood Culture Indentification, Gastrointestinal and Meningitis/Encephalitis panels. It provides up to six times more sample throughput per square foot of benchtop space.

  • 2016

    Acquisition of Hyglos (Germany)

    close
    2016
    photo-2016

    2016

    Acquisition of Hyglos (Germany)

    Acquisition of Hyglos, a company that brings bioMérieux a unique and recognized expertise in the development and production of recombinant proteins used for the detection of endotoxins in pharmaceutical products.

  • 2016

    Launch of EVISIGHT™ COMPACT

    close
    2016
    photo-2016

    2016

    Launch of EVISIGHT™ COMPACT

    A new automated diagnostic solution for microbial detection in pharmaceutical production and an intelligent incubator system providing real time culture media reading.

  • 2016

    Launch of EMAG® 

    close
    2016
    photo-2016

    2016

    Launch of EMAG® 

    A new molecular biology platform for the extraction of nucleic acids (DNA, RNA) that builds on the quality, robustness and ease of use that have made the NucliSENS® easyMAG® platform so successful. eMAG® features automation from the primary sample tube, greater traceability and higher throughput, in addition to an unparalleled degree of flexibility, not previously available on an automated system for the extraction of nucleic acids.

  • 2016

    Moving of the Campus de l’Étoile

     

    close
    2016
    photo-2016

    2016

    Moving of the Campus de l’Étoile

     

    The Compagny’s corporate functions are grouped on a new building in Marcy l’Étoile.

    It is located at the roots  of bioMérieux’s geographical center.

    The historic site in Marcy concentrates on production, quality and R&D activities.

     

  • 2017

    FDA clearance for VIDAS® B•R•A•H•M•S PCTTM  

     

    close
    2017
    photo-2017

    2017

    FDA clearance for VIDAS® B•R•A•H•M•S PCTTM  

     

    This automated test for the measurement of procalcitonin (PCT), a biological marker of bacterial infections, is an aid for antibiotic stewardship in respiratory infections and sepsis.

    It provides test results in 20 minutes.

  • 2017

    FDA 510(k) clearance for the BacT/ALERT® VIRTUO™ automated blood culture system

    close
    2017
    photo-2017

    2017

    FDA 510(k) clearance for the BacT/ALERT® VIRTUO™ automated blood culture system

    BacT/ALERT® VIRTUO™ is the first continuously-monitoring blood culture microbial detection system to offer “Load & Go” technology, helping labs to streamline their workflow. It is now commercially available in countries that recognize CE marking and in the United States.

  • 2017

    FDA clearance for BIOFIRE® FILMARRAY® RP2, CE marked for RP2 plus

    close
    2017
    photo-2017

    2017

    FDA clearance for BIOFIRE® FILMARRAY® RP2, CE marked for RP2 plus

    The Respiratory BIOFIRE® FILMARRAY® 2 (RP2) panel, enriched version of the Respiratory BIOFIRE® FILMARRAY® panel, tests in 45 minutes 21 pathogens (17 viruses and 4 bacteria) responsible for respiratory tract infections. It incorporates an additional pathogen, Bordetella parapertussis, one of the causative agents of pertussis or whooping cough.

    The BIOFIRE® FILMARRAY® RP2 plus includes one additional pathogen: Middle East Respiratory Syndrome coronavirus (MERS-CoV).

  • 2017

    FDA clearance for RAPIDEC® CARBA NP test

     

     

    close
    2017
    photo-2017

    2017

    FDA clearance for RAPIDEC® CARBA NP test

     

     

    This test was developed for cases where microorganisms are resistant to carbapenems (a very broad spectrum antibiotic class).

    Il enables the detection of carbapenemase producers within 2 hours. 

  • 2017

    FDA clearance for expanded pathogen identification capability on VITEK® MS

     

     

    close
    2017
    photo-2017

    2017

    FDA clearance for expanded pathogen identification capability on VITEK® MS

     

     

    VITEK® MS, rapid pathogen identification, has received 510(k) clearance from the FDA for the expanded identification of mycobacteria, Nocardia and moulds.

    • A  database of  more than 15,000  strains
    • For the first time, enables the safe identification of the Mycobacterium tuberculosis (TB) group

     

  • 2017

    Alexandre Mérieux appointed Chairman and CEO of bioMérieux

     

    close
    2017
    photo-2017

    2017

    Alexandre Mérieux appointed Chairman and CEO of bioMérieux

     

    After serving as CEO of bioMérieux for the last three years, Alexandre Mérieux succeeds Jean-Luc Bélingard, who had been Chairman of the Company since 2010.

    As the next Mérieux generation takes up the position of Chairman and CEO, this appointment marks the continuity of the family’s role in the Company.

     

     

  • 2018

    Acquisition of Astute Medical (United-States)

     

    close
    2018
    photo-2018

    2018

    Acquisition of Astute Medical (United-States)

     

    Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers.

    Astute developed the NEPHROCHECK® test, an FDA-cleared test for the early risk assessment of acute kidney injuries (AKI).

    This acquisition follows a development and commercialization partnership signed in 2015 with Astute to develop and market the NEPHROCHECK® test, for the VIDAS® automated immunoassay system. It reinforces bioMérieux’s offering of High Medical Value immunoassay biomarkers.

    Fruitful partnership developed in 2015 between Astute Medical and bioMérieux when Astute granted bioMérieux a license to develop and market the NEPHROCHECK® test for the VIDAS® automated immunoassay system

     

  • 2018

    ENDOZYME® II GO launch

     

     

    close
    2018
    photo-2018

    2018

    ENDOZYME® II GO launch

     

     

    • A new innovative test for the detection of endotoxins in pharmaceutical microbiology control.
    • The result of the combined expertise of bioMérieux in microbiology and Hyglos GmbH in endotoxin detection.

     

  • 1963
  • 1967
  • 1969
  • 1972
  • 1974
  • 1979
  • 1985
  • 1986
  • 1988
  • 1989
  • 1990
  • 1991
  • 1992
  • 1995
  • 1997
  • 2001
  • 2002
  • 2004
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018